Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PneuMum: Pneumococcal Vaccination for Indigenous Mothers to Protect Babies From Ear Disease
NCT00310349Phase 3Unknown
- Sponsor
- University of Melbourne
- Start
- Mar 2006
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of 23-valent pneumococcal polysaccharide vaccine in otitis media, pneumococcal infection, middle ear effusion (MEE), tympanic membrane perforation, sponsored by University of Melbourne. Status: unknown.
02
Drugs
23-valent pneumococcal polysaccharide vaccine
03
Conditions
otitis mediapneumococcal infectionmiddle ear effusion (MEE)tympanic membrane perforation
Beyond the preview
Go deeper on NCT00310349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00310349.